Optimization of 2-phenyl-pyrimidine-4-carboxamides towards potent, orally bioavailable and selective P2Y12 antagonists for inhibition of platelet aggregation
Keywords: P2Y12 receptor; P2Y12 antagonist; GPCR antagonist; Antiplatelet; Antithrombotic;